E3A Healthcare
Company Timeline
2019
Our journey began with a vision to improve the quality of care for newborns and women worldwide. Established at NUS in 2019, we embarked on our journey to create accessible and effective medical devices that addresses overlooked demands
2020
In 2020, we initiated the development of our first product - the YSJ series smart newborn jaundice meters. We also established our Hong Kong and Shenzhen offices to expand into the Greater China markets
2021
In 2021, we finished the development and clinical trials for our YSJ series bilirubin meter product. Furthermore, We have completed the setup of a medical device manufacturing facility in Shenzhen, which is certified with ISO-13485 standards., finalizing our capabilities for in-house development and fabrication of innovative medical devices
2022
We received Class II medical device clearance for our smart jaundice meter product from the Chinese FDA (NMPA) and pioneered the rental model for at-home jaundice monitoring. Currently, we serve over 120 hospitals across China, covering over 500K newborns annually
2023 and Beyond
2023 is our year of rapid growth and expansion. As we establish a leading market position with our jaundice management services, our next step is the global markets, with plans to expand into Southeast Asia and North America. The launch of our first women’s health device is also scheduled in 2024
Management Team
2021 Forbes 30 Under 30 ; Optoelectronics expert; Former PI in multiple SG National Science Foundation projects; Received Ph.D. in Bioengineering from NUS
CEO and Founder
Dean, AIT College of Engineering, Professor at NUS; Esteemed scholar in analytical chemistry；Founder of multiple biotech companies, raised over 60M USD
Chief Scientific Officer
Top scholars in the fields of metabolism, animal physiology, and genomics; current member of the editorial board of Science journal; academicians of the national academies of sciences in China, US and UK.
Chief Science Advisor
Serial Biotech Entrepreneur, previous company acquired; California CPA; Former Silicon Valley Investor; Studied Economics at UC Berkeley
Chief Financial Officer
Ex-Physician; Former Research Director at Nepal Science Institute; Received Masters in Public Health from Johns Hopkins and BioEngPh.D. from NUS
Chief Technology Officer
Advisory Team
Former Chief Technology Officer of Medtronic, Vice President of Covidien; experienced expert in the medical device industry, managing over $10 billion in annual revenue
Chief Technical Advisor
Fellow of the Royal College of Paediatrics and Child Health in the UK, expert in neonatal clinical medicine; former head of neonatology at the National University Hospital in Singapore; leader in maternal and child health care in Singapore
Chief Clinical Advisor
OUR OFFICES
Singapore
*Headquarters
83 Science Park Road, #02-03, Curie, 118258
Unit 502, Building 19W, HKSTP, Pak Shek Kok, N.T.
Hong Kong
16F, Tower B, ITH, Nanshan, Shenzhen, Guangdong, China
Shenzhen
Silicon Valley
1520 Sand Hill Road, Palo Alto, CA, United States, 94304